What is the ticker symbol for BridgeBio Pharma, Inc.?

The ticker symbol for BridgeBio Pharma, Inc. is NASDAQ:BBIO

Does BridgeBio Pharma, Inc. pay dividends?

No, BridgeBio Pharma, Inc. does not pay dividends

What sector is BridgeBio Pharma, Inc. in?

BridgeBio Pharma, Inc. is in the Healthcare sector

What industry is BridgeBio Pharma, Inc. in?

BridgeBio Pharma, Inc. is in the Biotechnology industry

What country is BridgeBio Pharma, Inc. based in?

BridgeBio Pharma, Inc. is headquartered in United States

When did BridgeBio Pharma, Inc. go public?

BridgeBio Pharma, Inc. initial public offering (IPO) was on June 27, 2019

Is BridgeBio Pharma, Inc. in the S&P 500?

No, BridgeBio Pharma, Inc. is not included in the S&P 500 index

Is BridgeBio Pharma, Inc. in the NASDAQ 100?

No, BridgeBio Pharma, Inc. is not included in the NASDAQ 100 index

Is BridgeBio Pharma, Inc. in the Dow Jones?

No, BridgeBio Pharma, Inc. is not included in the Dow Jones index

When was BridgeBio Pharma, Inc. last earnings report?

BridgeBio Pharma, Inc.'s most recent earnings report was on October 29, 2026

When does BridgeBio Pharma, Inc. report earnings?

The next expected earnings date for BridgeBio Pharma, Inc. is February 23, 2027

BBIO Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, BBIO price is $74.27, down -4.65% on November 5, 2026
Current Price All-Time High: BBIO price is currently -20.49% below its historical high of $93.42 set on July 9, 2026
Market Cap: BBIO current market cap is $14B, up +19.86% over the past 365 days
Revenue: BBIO current annual revenue is $502.08M, up +126.26% year-over-year
Next Earnings: The next earnings release for BBIO is on February 23, 2027

Profile

Company profile for BridgeBio Pharma, Inc. (BBIO)
Metric	Value
Full Name	BridgeBio Pharma, Inc.
Ticker	NASDAQ: BBIO
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Jun 27, 2019
Indexes	Not included
Website	bridgebio.com
Employees	725

Key Metrics

BridgeBio Pharma, Inc. Key Details
Metric	Value	Date
Price	$74.27	Nov 5, 26
Price, 1D Change	-4.65%	Nov 5, 26
Market Cap	$14B	Nov 5, 26
	-	Nov 5, 26
PE Ratio	-	Nov 5, 26
Beta	0.93	Nov 5, 26
Revenue	$502.08M	Dec 31, 25
Revenue, 1Y Change	+126.26%	Dec 31, 25
EPS	-$3.79	Dec 31, 25
EPS, 1Y Change	-31.46%	Dec 31, 25

Events

BridgeBio Pharma, Inc. Events
Metric	Value	Date
Next Earnings		Feb 23, 27
Last Qtr. Earnings		Oct 29, 26
Last Ann. Earnings		Feb 24, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

BBIO Estimates
Metric	Value	Date
EPS	-$3.79	Dec 31, 25
EPS Estimate	-$2.60	Feb 23, 27
EPS Est. Change	+31.33%	Feb 23, 27
Revenue	$502.08M	Dec 31, 25
Revenue Estimate	$1.09B	Feb 23, 27
Revenue Est. Change	+117.20%	Feb 23, 27
Current Price	$74.27	Nov 5, 26
Price Target	$108.50	-
Price Tgt. Change	+46.09%	-

🔒 Log In To Unlock Full Data

EPS

BBIO EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$2.39	-$2.88	-20.37%
2025	-$3.19	-$3.79	-18.65%
2026	-$2.60	N/A	+31.33%
2027	-$0.05	N/A	+98.59%

Revenue

BBIO revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$281.76M	$221.90M	-21.24%
2025	$497.54M	$502.08M	+0.91%
2026	$1.09B	N/A	+117.20%
2027	$1.67B	N/A	+232.81%

🔒 Log In To Unlock Full Data

Performance

BBIO Performance
Metric	Value	Date
Price, 1Y	+18.53%	Nov 5, 26
Price, 3Y	+157.61%	Nov 5, 26
Market Cap, 1Y	+19.86%	Nov 5, 26
Market Cap, 3Y	+188.19%	Nov 5, 26
Revenue, 1Y	+126.26%	Dec 31, 25
Revenue, 3Y	+546.61%	Dec 31, 25
EPS, 1Y	-31.46%	Dec 31, 25
EPS, 3Y	-16.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

BBIO Technical Indicators
Metric	Value	Date
Current Price	$74.27	Nov 5, 26
SMA 200	$72.71	Nov 5, 26
SMA 50	$69.85	Nov 5, 26
EMA 200	$70.42	Nov 5, 26
EMA 50	$71.04	Nov 5, 26
MACD	$1.74	Nov 5, 26
Beta	0.93	Nov 5, 26
ATR	$2.70	Nov 5, 26
14-Day RSI	59.93	Nov 5, 26
10-Day Volatility	49.12%	Nov 5, 26

Dividends

BBIO Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Nov 5, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

BBIO Income & Profitability
Metric	Value	Date
Revenue	$502.08M	Dec 31, 25
EPS	-$3.79	Dec 31, 25
Gross Profit	$478.38M	Dec 31, 25
Gross Margin	95.28%	Dec 31, 25
Operating Income	-$502.06M	Dec 31, 25
Operating Margin	-100.00%	Dec 31, 25
Net Income	-$732.94M	Dec 31, 25
Net Margin	-145.98%	Dec 31, 25
EBITDA	-$496.63M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

BBIO Financial Health
Metric	Value	Date
Debt To Equity	-1.31	Dec 31, 25
	2.77	Dec 31, 25
	2.68	Dec 31, 25
	-	Dec 31, 25
	3	Sep 30, 26
	-3.41	Nov 5, 26

Valuations

BBIO Valuations
Metric	Value	Date
PE Ratio	-	Nov 5, 26
	15.30	Nov 5, 26
	-5.55	Nov 5, 26
	-46.91	Nov 5, 26
	-	N/A

Balance Sheet

BBIO Balance Sheet
Metric	Value	Date
Book Value	-$2.09B	Dec 31, 25
	$588.03M	Dec 31, 25
	$936.03M	Dec 31, 25
	$797.75M	Dec 31, 25
	$3.01B	Dec 31, 25
	$287.97M	Dec 31, 25
Total Debt	$2.73B	Dec 31, 25
	$17.41M	Dec 31, 25
	$36.23M	Dec 31, 25

Expenses

BBIO Expenses
Metric	Value	Date
	$1.23B	Dec 31, 25
	$980.44M	Dec 31, 25
	$23.70M	Dec 31, 25
	$0.00	Dec 31, 25
	$5.43M	Dec 31, 25
	$0.00	Dec 31, 25
	$435.00K	Dec 31, 25

Cash Flow

BBIO Cash Flow
Metric	Value	Date
	-$445.91M	Dec 31, 25
	-$22.34M	Dec 31, 25
	$357.14M	Dec 31, 25
Capex	$9.59M	Dec 31, 25
	-$455.50M	Dec 31, 25

Recent analyst updates

BBIO Recent analyst updates
Metric	Value	Date
TD Cowen	→	Oct 30, 26
Morgan Stanley	→	Oct 30, 26
Morgan Stanley	→	Oct 21, 26
Piper Sandler	→	Oct 19, 26
Citigroup	→	Oct 19, 26
Barclays	→	Oct 7, 26
HC Wainwright & Co.	→	Sep 10, 26
HC Wainwright & Co.	→	Sep 2, 26
Mizuho	→	Sep 1, 26
Truist Securities	→	Aug 12, 26

Analyst sentiment

Institutional ownership

Screeners with BBIO

FAQ

What is the ticker symbol for BridgeBio Pharma, Inc.?: The ticker symbol for BridgeBio Pharma, Inc. is NASDAQ:BBIO
Does BridgeBio Pharma, Inc. pay dividends?: No, BridgeBio Pharma, Inc. does not pay dividends
What sector is BridgeBio Pharma, Inc. in?: BridgeBio Pharma, Inc. is in the Healthcare sector
What industry is BridgeBio Pharma, Inc. in?: BridgeBio Pharma, Inc. is in the Biotechnology industry
What country is BridgeBio Pharma, Inc. based in?: BridgeBio Pharma, Inc. is headquartered in United States
When did BridgeBio Pharma, Inc. go public?: BridgeBio Pharma, Inc. initial public offering (IPO) was on June 27, 2019
Is BridgeBio Pharma, Inc. in the S&P 500?: No, BridgeBio Pharma, Inc. is not included in the S&P 500 index
Is BridgeBio Pharma, Inc. in the NASDAQ 100?: No, BridgeBio Pharma, Inc. is not included in the NASDAQ 100 index
Is BridgeBio Pharma, Inc. in the Dow Jones?: No, BridgeBio Pharma, Inc. is not included in the Dow Jones index
When was BridgeBio Pharma, Inc. last earnings report?: BridgeBio Pharma, Inc.'s most recent earnings report was on October 29, 2026
When does BridgeBio Pharma, Inc. report earnings?: The next expected earnings date for BridgeBio Pharma, Inc. is February 23, 2027

Data Sources & References

BBIO Official Website bridgebio.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1743881/000174388126000009/0001743881-26-000009-index.htm
BBIO Profile on Yahoo Finance finance.yahoo.com/quote/BBIO
BBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbio